• Admin
    UC Research Repository
    View Item 
       
    • UC Home
    • Library
    • UC Research Repository
    • College of Business and Law
    • Business and Law: Theses and Dissertations
    • View Item
       
    • UC Home
    • Library
    • UC Research Repository
    • College of Business and Law
    • Business and Law: Theses and Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of the RepositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    Statistics

    View Usage Statistics

    An analysis of TRIPS-plus protections relating to pharmaceuticals and geographical indications in CETA and the CPTPP Implications for a European Union – New Zealand Free Trade Agreement.

    Thumbnail
    View/Open
    McLellan, Bridgette_Master's Thesis.pdf (1.004Mb)
    Author
    McLellan, Bridgette Kathleen
    Date
    2019
    Permanent Link
    http://hdl.handle.net/10092/16938
    Thesis Discipline
    Law
    Degree Grantor
    University of Canterbury
    Degree Level
    Masters
    Degree Name
    Master of Laws

    On 29 October 2015, the European Union (EU) and New Zealand announced their intention to commence the process for negotiations to achieve a bilateral Free Trade Agreement (FTA). Closer trade relations would undoubtedly provide immense economic benefits to New Zealand. It would, however, come at a cost in certain areas. One area where concerns have been raised relates to intellectual property (IP) and the increasing trend of including higher levels or ‘TRIPS-plus’ protections in FTAs. This is particularly so in relation to pharmaceuticals and geographical indications, as stronger IP protection in those areas would come at a significant cost to New Zealand. Given the confidential nature of trade negotiations, the extent to which TRIPS-plus protections may be included within an EU-NZ FTA and the implications for New Zealand law remain unknown. This thesis seeks to address this issue.

    First, a comparative interpretative analysis of TRIPS-plus protections relating to pharmaceuticals and geographical indications within recent FTAs concluded by each Party shall be conducted to identify those protections which may be included within an EU-NZ FTA. A further analysis shall be conducted to determine the domestic positions of the EU and New Zealand in order to shed light on the context of those FTAs and to identify any common interests or positions regarding IP protection. By succinctly identifying those TRIPS-plus protections which could be included within an EU-NZ FTA, a further discussion on the implications for New Zealand will then ensue. This discussion will seek to address such issues as whether New Zealand should implement TRIPS-plus protections and, if so, to what extent.

    Collections
    • Business and Law: Theses and Dissertations [401]
    Rights
    https://canterbury.libguides.com/rights/theses

    UC Research Repository
    University Library
    University of Canterbury
    Private Bag 4800
    Christchurch 8140

    Phone
    364 2987 ext 8718

    Email
    ucresearchrepository@canterbury.ac.nz

    Follow us
    FacebookTwitterYoutube

    © University of Canterbury Library
    Send Feedback | Contact Us